A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells

Experimental Cell Research

Volumn 314, Issue 11-12, 2008, Pages 2176-2186

  Nedeau, April E ^a   Bauer, Richard J ^a   Gallagher, Katherine ^a   Chen, Haiying ^a   Liu, Zhao Jun ^a   Velazquez, Omaida C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Basic fibroblast growth factor (bFGF); Bone marrow derived mesenchymal stem cells; Endothelial neutrophil activating peptide 78 (ENA 78) or CXCL5; Fibroblasts; Platelet derived growth factor B (PDGF B); Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; COLLAGEN GEL; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN MICROARRAY; SUPERNATANT; TRANSGENIC MOUSE; VELOCITY; WOUND HEALING;

ENA; MUS MUSCULUS;

EID: 44949198395     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.04.007     Document Type: Article

References (35)

1. Marchese C., Felici A., Visco V., Lucania G., Igarashi M., Picardo M., Frati L., and Torrisi M.R. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J. Invest. Dermatol. 116 (2001) 623-628
2. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., and Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev., Mol. Cell Biol. 3 (2002) 349-363
3. Chesney J., Metz C., Stavitsky A.B., Bacher M., and Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160 (1998) 419-425
4. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., and Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
5. Phillips T.J. Chronic cutaneous ulcers: etiology and epidemiology. J. Invest. Dermatol. 102 (1994) 38S-41S
6. Harding K.G., Moore K., and Phillips T.J. Wound chronicity and fibroblast senescence-implications for treatment. Int. Wound J. 2 (2005) 364-368
7. Stanley A.C., Fernandez N.N., Lounsbury K.M., Corrow K., Osler T., Healey C., Forgione P., Shackford S.R., and Ricci M.A. Pressure-induced cellular senescence: a mechanism linking venous hypertension to venous ulcers. J. Surg. Res. 124 (2005) 112-117
8. Raines E.W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 15 (2004) 237-254
9. Alvarez R.H., Kantarjian H.M., and Cortes J.E. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin. Proc. 81 (2006) 1241-1257
10. Hart C.E., Forstrom J.W., Kelly J.D., Seifert R.A., Smith R.A., Ross R., Murray M.J., and Bowen-Pope D.F. Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240 (1988) 1529-1531
11. Fang L., Yan Y., Komuves L.G., Yonkovich S., Sullivan C.M., Stringer B., Galbraith S., Lokker N.A., Hwang S.S., Nurden P., Phillips D.R., and Giese N.A. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 787-792
12. Kohler N., and Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp. Cell Res. 87 (1974) 297-301
13. Ross R., Glomset J., Kariya B., and Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 1207-1210
14. Gilardetti R.S., Chaibi M.S., Stroumza J., Williams S.R., Antoniades H.N., Carnes D.C., and Graves D.T. High-affinity binding of PDGF-AA and PDGF-BB to normal human osteoblastic cells and modulation by interleukin-1. Am. J. Physiol. 261 (1991) C980-C985
15. Ross R., Raines E.W., and Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell 46 (1986) 155-169
16. Pierce G.F., Vande Berg J., Rudolph R., Tarpley J., and Mustoe T.A. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am. J. Pathol. 138 (1991) 629-646
17. Pierce G.F., Mustoe T.A., Lingelbach J., Masakowski V.R., Griffin G.L., Senior R.M., and Deuel T.F. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109 (1989) 429-440
18. Nesbit M., Schaider H., Berking C., Shih D.T., Hsu M.Y., McBrian M., Crombleholme T.M., Elenitsas R., Buck C., and Herlyn M. Alpha5 and alpha2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin. Lab. Invest. 81 (2001) 1263-1274
19. Pierce G.F., Tarpley J.E., Tseng J., Bready J., Chang D., Kenney W.C., Rudolph R., Robson M.C., Vande Berg J., Reid P., Kaufman S., and Farrell C.L. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J. Clin. Invest. 96 (1995) 1336-1350
20. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., and Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
21. Keswani S.G., Katz A.B., Lim F.Y., Zoltick P., Radu A., Alaee D., Herlyn M., and Crombleholme T.M. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen. 12 (2004) 497-504
22. Schnurch H., and Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119 (1993) 957-968
23. Gospodarowicz D., and Moran J.S. Stimulation of division of sparse and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulin. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 4584-4588
24. Walz A., Burgener R., Car B., Baggiolini M., Kunkel S.L., and Strieter R.M. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174 (1991) 1355-1362
25. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115 (2005) 3339-3347
26. Wall L., Burke F., Barton C., Smyth J., and Balkwill F. IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin. Cancer Res. 9 (2003) 2487-2496
27. Appay V., and Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 22 (2001) 83-87
28. Miyata T., Iizasa H., Sai Y., Fujii J., Terasaki T., and Nakashima E. Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J. Cell. Physiol. 204 (2005) 948-955
29. Mann A., Breuhahn K., Schirmacher P., and Blessing M. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J. Invest. Dermatol. 117 (2001) 1382-1390
30. Siegbahn A., Hammacher A., Westermark B., and Heldin C.H. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J. Clin. Invest. 85 (1990) 916-920
31. Seah C.C., Phillips T.J., Howard C.E., Panova I.P., Hayes C.M., Asandra A.S., and Park H.Y. Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway. J. Invest. Dermatol. 124 (2005) 466-474
32. Loots M.A., Lamme E.N., Mekkes J.R., Bos J.D., and Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch. Dermatol. Res. 291 (1999) 93-99
33. Raffetto J.D., Mendez M.V., Marien B.J., Byers H.R., Phillips T.J., Park H.Y., and Menzoian J.O. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid. J. Vasc. Surg. 33 (2001) 1233-1241
34. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124 (1994) 401-404
35. Hinz B., Pittet P., Smith-Clerc J., Chaponnier C., and Meister J.J. Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol. Biol. Cell 15 (2004) 4310-4320